Obtained More than $40 Million in Settlements for Victims of Alleged Blood Reagents Price-Fixing Conspiracy

October 25, 2018

In re: Blood Reagents Antitrust Litigation, 09-md-02081 (E.D. Penn.)

Robins Kaplan served on the executive committee in this class action, which alleged that defendants Ortho Clinical Diagnostics, Inc., a former Johnson & Johnson subsidiary, colluded with Immucor, Inc. to raise prices on traditional blood reagents, which are used to test blood before transfusions and donations. Aggregate settlements totaled more than $40 million and the case concluded in October 2018. Notably, the Department of Justice had initially opened a criminal investigation into defendants’ practices, but subsequently closed the investigation without taking any action.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Similar Results

Back to Top